VIA

Virtus Investment Advisers Portfolio holdings

AUM $368M
1-Year Est. Return 26.25%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+26.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$349M
AUM Growth
+$53.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
478
New
Increased
Reduced
Closed

Top Buys

1 +$2.36M
2 +$1.99M
3 +$1.97M
4
IDXX icon
Idexx Laboratories
IDXX
+$1.96M
5
TKO icon
TKO Group
TKO
+$1.96M

Top Sells

1 +$1.85M
2 +$1.62M
3 +$1.62M
4
CBRE icon
CBRE Group
CBRE
+$1.61M
5
NU icon
Nu Holdings
NU
+$1.58M

Sector Composition

1 Financials 33.25%
2 Healthcare 17.27%
3 Technology 14.61%
4 Industrials 8.9%
5 Consumer Discretionary 5.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QURE icon
226
uniQure
QURE
$974M
$415K 0.12%
7,116
+1,235
OXSQ icon
227
Oxford Square Capital
OXSQ
$145M
$397K 0.11%
249,916
+29,428
MSIF
228
MSC Income Fund Inc
MSIF
$579M
$396K 0.11%
+30,158
GERN icon
229
Geron
GERN
$1.07B
$390K 0.11%
284,868
GLAD icon
230
Gladstone Capital
GLAD
$411M
$387K 0.11%
17,698
-4,435
NCDL icon
231
Nuveen Churchill Direct Lending
NCDL
$636M
$387K 0.11%
28,008
+5,555
LEGN icon
232
Legend Biotech
LEGN
$3.51B
$382K 0.11%
11,722
VRTX icon
233
Vertex Pharmaceuticals
VRTX
$126B
$378K 0.11%
966
HRMY icon
234
Harmony Biosciences
HRMY
$1.64B
$367K 0.11%
13,333
ZLAB icon
235
Zai Lab
ZLAB
$2.15B
$350K 0.1%
10,328
IBRX icon
236
ImmunityBio
IBRX
$9.63B
$343K 0.1%
139,309
RARE icon
237
Ultragenyx Pharmaceutical
RARE
$2.26B
$340K 0.1%
11,311
BCRX icon
238
BioCryst Pharmaceuticals
BCRX
$2.17B
$324K 0.09%
42,730
RAPP
239
Rapport Therapeutics
RAPP
$1.38B
$303K 0.09%
10,214
+1,773
ADMA icon
240
ADMA Biologics
ADMA
$3.71B
$302K 0.09%
20,574
MLYS icon
241
Mineralys Therapeutics
MLYS
$2.32B
$289K 0.08%
7,626
+1,324
OLMA icon
242
Olema Pharmaceuticals
OLMA
$1.94B
$274K 0.08%
28,026
+4,865
TRML
243
DELISTED
Tourmaline Bio
TRML
$273K 0.08%
5,718
+993
ARWR icon
244
Arrowhead Research
ARWR
$8.86B
$242K 0.07%
7,015
+1,218
NTLA icon
245
Intellia Therapeutics
NTLA
$1.6B
$235K 0.07%
13,627
+2,366
NUVB icon
246
Nuvation Bio
NUVB
$2.03B
$233K 0.07%
62,866
+10,914
DNTH icon
247
Dianthus Therapeutics
DNTH
$2.39B
$232K 0.07%
5,899
+1,024
SRPT icon
248
Sarepta Therapeutics
SRPT
$1.76B
$230K 0.07%
11,911
CNTA
249
Centessa Pharmaceuticals
CNTA
$3.97B
$229K 0.07%
9,451
+1,641
COGT icon
250
Cogent Biosciences
COGT
$6.31B
$226K 0.06%
15,760
+2,736